verapamil has been researched along with enalapril in 83 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (10.84) | 18.7374 |
| 1990's | 34 (40.96) | 18.2507 |
| 2000's | 23 (27.71) | 29.6817 |
| 2010's | 17 (20.48) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
| Avdeef, A; Tam, KY | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bartolucci, G; Coronnello, M; Dei, S; Manetti, D; Romanelli, MN; Salerno, M; Teodori, E; Udomtanakunchai, C | 1 |
| Frattola, A; Mancia, G; Omboni, S; Ravogli, A; Villani, A | 1 |
| Donato, L; Marabotti, C; Neglia, D; Palombo, C; Parodi, O; Sambuceti, G | 1 |
| Beretta-Piccoli, C; Ferrari, P; Ferrier, C; Keller, U; Riesen, WF; Weidmann, P | 2 |
| Angermann, CE; Dominiak, P; Gerzer, R; Kemkes, BM; Spes, CH; Stempfle, HU; Theisen, K; Weil, J | 1 |
| Andersen, GN | 1 |
| Amery, A; Fagard, R; Lijnen, P; Vanhees, L | 1 |
| Ayache, AS; Groshar, D; Traub, YM | 1 |
| Angermann, CE; Dominiak, P; Kemkes, BM; Spes, CH; Theisen, K; Willems, S | 2 |
| Fagher, B; Henningsen, NC; Hulthén, UL; Katzman, P; Thulin, T | 1 |
| Fogo, A; Ichikawa, I; Yared, A; Yoshida, Y | 1 |
| Bassett, AH; el Nahas, AM; Le Carpentier, JE; Wight, JP | 1 |
| Fagher, B; Henningsen, N; Hulthén, L; Katzman, P; Thulin, T | 1 |
| Cubela, R; Debrevi, L; Jackson, B; Johnston, CI; Whitty, M | 1 |
| Bianco, G; Cellamare, G; Poppa, E; Sgobba, G | 1 |
| Bock, HA; Brunner, FP; Hermle, M; Mihatsch, MJ; Thiel, G | 1 |
| Angermann, CE; Anthuber, M; Kemkes, BM; Spes, CH; Theisen, K | 1 |
| Jackson, B; Whitty, MR | 1 |
| Koster, M | 1 |
| Birkenhäger, WH; de Leeuw, PW; van Soest, GA | 1 |
| Lowenthal, DT | 1 |
| Catalano, M; Libretti, A | 1 |
| Cargo, P; Ferdinand, KC; Laine, H; Lefkowitz, M; Levine, JH | 1 |
| Collins, TJ; Mehra, MR; Ramee, SR; Smart, FW; Stapleton, DD; Ventura, HO | 1 |
| Dämmrich, J; Heidland, A; Ling, H; Schaefer, L; Schaefer, RM; Suzuki, H; Teschner, M | 1 |
| Barrientos, A; Borque, M; González-Mate, A; Herrero, JA; Marcello, M; Torralbo, A; Trobo, JI; Velasco, E | 1 |
| Carotenuto, A; Cuocolo, A; de Divitiis, M; de Divitiis, O; Di Somma, S; Galderisi, M; Paulucci, A | 1 |
| Cohen, EP; Fish, BL; Hill, P; Moulder, JE | 1 |
| Karlson-Stiber, C; Ostergren, J; Rosenberg, J; Svensson, P | 1 |
| Bujor, MA; Davis, BB; Myles, PS; Olenikov, I | 1 |
| Arvidsson, N; Herlitz, H; Lukes, D; Mjörnstedt, L; Olausson, M | 2 |
| Agostoni, P; Guazzi, M; Loaldi, A | 1 |
| Fletcher, RD; Kokkinos, PF; Narayan, P; Papademetriou, V; Tsagadopoulos, D | 1 |
| Cohen, A; Erlich, Y; Rosenmann, E; Rosenthal, T | 1 |
| Gallopin, M; Giorgetti, A; L'Abbate, A; Marabotti, C; Neglia, D; Palombo, C; Parodi, O; Sambuceti, G; Simonetti, I | 1 |
| Cholewa, M; Gralec, M; Piusińska-Macoch, A; Sułek, K | 1 |
| Oken, RJ | 1 |
| Iversen, BM; Kvam, FI; Ofstad, J | 1 |
| Alsina, J; Grinyó, JM; Hueso, M; Martínez-Castelao, A; Rejas, J; Sanz, V | 1 |
| Gordeladze, JO; Jynge, P; Sellevold, OF | 1 |
| Kim, SB; Lee, SK; Park, JS; Park, JY; Park, SK; Yang, WS; Yu, ES | 1 |
| Mandarim-de-Lacerda, CA; Meirelles Pereira, LM | 1 |
| Guelpa, G | 1 |
| Mandarim-de-Lacerda, CA; Pereira, LM | 4 |
| Candy, GP; Den Hond, E; Libhaber, C; Libhaber, E; Radevski, IV; Sareli, P; Skudicky, D; Staessen, JA; Valtchanova, ZP; Wang, JG | 1 |
| Abrignani, MG; Barbagallo, M; Dominguez, LJ; Nardi, E; Novo, G; Novo, S; Strano, A | 1 |
| Fernández, R; Garrido, J; Puig, JG; Redon, J; Rodríguez-Pérez, JC | 1 |
| Anders, RJ; Bakris, G; Fagan, T; Ram, V; Sica, D; Vaitkus, PT | 1 |
| Candy, G; Libhaber, E; Radevski, I; Sareli, P; Skudicky, D; Staessen, JA; Thijs, L; Tshele, E; Valtchanova, Z; Wang, JG | 1 |
| Anders, RJ; Calhoun, D; Mansoor, GA; Sica, DA; White, WB | 1 |
| Madeira, AC; Mandarim-de-Lacerda, CA; Pereira, LM | 1 |
| Iversen, BM; Myking, O; Ofstad, J; Svarstad, E | 1 |
| Bezerra, DG; Mandarim-de-Lacerda, CA; Pereira, LM | 1 |
| Karpov, IuA | 1 |
| Antopolsky, M; Chajek-Shaul, T; Hasin, T; Leibowitz, D | 1 |
| Antequera, R; Cedeño, J; Estrada, O; León, L; Romero-Vecchione, E; Rosa, F; Vásquez, J | 1 |
| Austin, RP; Barton, P; Wenlock, MC | 1 |
| Efimova, IIu; Kalashnikova, TP; Lishmanov, IuB | 1 |
| Linnet, K; Rasmussen, HB; Thomsen, R | 1 |
| Abolghasemi, R; Argani, H; Atabak, S; Rahmani, L; Taziki, O; Zangneh, HF | 1 |
| Jansook, P; Loftsson, T; Muankaew, C; Stefánsson, E | 1 |
| Caprioli, RM; Chumbley, CW; Hachey, BC; Norris, JL; Prentice, BM | 1 |
| Alexandrescu, D; Fabi, S; Fitzpatrick, RE; Goldman, MP; Yeh, LC | 1 |
6 review(s) available for verapamil and enalapril
| Article | Year |
|---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Ambulatory blood pressure monitoring.
Topics: Blood Pressure Monitors; Double-Blind Method; Enalapril; Humans; Hypertension; Nitrendipine; Verapamil | 1992 |
Regional myocardial blood flow and coronary reserve in hypertensive patients. The effect of therapy.
Topics: Adult; Coronary Circulation; Enalapril; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Regional Blood Flow; Verapamil | 1992 |
[Ischemic heart disease combined with hypertension: peculiarities of course and selection of therapy].
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Controlled Clinical Trials as Topic; Enalapril; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Myocardial Ischemia; Nifedipine; Perindopril; Placebos; Risk Factors; Surveys and Questionnaires; Time Factors; Vasodilator Agents; Verapamil | 2005 |
Comparative Results in Treatment of Keloids With Intralesional 5-FU/Kenalog, 5-FU/Verapamil, Enalapril Alone,Verapamil Alone, and Laser: A Case Report and Review of the Literature.
Topics: Adult; Drug Therapy, Combination; Enalapril; Fluorouracil; Humans; Injections, Intralesional; Keloid; Laser Therapy; Male; Treatment Outcome; Triamcinolone Acetonide; Verapamil | 2016 |
21 trial(s) available for verapamil and enalapril
| Article | Year |
|---|---|
Regional myocardial blood flow and coronary reserve in hypertensive patients. The effect of therapy.
Topics: Adult; Coronary Circulation; Enalapril; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Regional Blood Flow; Verapamil | 1992 |
Swiss hypertension treatment programme with verapamil and/or enalapril in diabetic patients.
Topics: Adolescent; Adult; Aged; Blood Glucose; Blood Pressure; Creatinine; Diabetes Complications; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Switzerland; Verapamil | 1992 |
Effect of antihypertensive medication on endurance exercise capacity in hypertensive sportsmen.
Topics: Adult; Antihypertensive Agents; Atenolol; Double-Blind Method; Enalapril; Exercise Test; Humans; Hypertension; Male; Physical Endurance; Sports; Verapamil | 1991 |
Antihypertensive therapy with Ca2+. Antagonist verapamil and/or ACE inhibitor enalapril in NIDDM patients.
Topics: Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enalapril; Female; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged; Proteinuria; Verapamil | 1991 |
The effect of enalapril and calcium antagonists on blood pressure and cerebral perfusion in elderly hypertensives.
Topics: Aged; Blood Pressure; Cerebrovascular Circulation; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Single-Blind Method; Verapamil | 1991 |
Antihypertensive efficacy and tolerability of enalapril and slow-release verapamil in essential hypertension: a double-blind, cross-over study.
Topics: Adult; Age Factors; Aged; Blood Pressure; Delayed-Action Preparations; Double-Blind Method; Electrocardiography; Enalapril; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Quality of Life; Renin; Single-Blind Method; Verapamil | 1991 |
Antihypertensive and renal effects of enalapril and slow-release verapamil in essential hypertension. A double-blind, randomized study.
Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Delayed-Action Preparations; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Kidney; Male; Middle Aged; Renin; Verapamil | 1990 |
Lipid profile during antihypertensive treatment. The SLIP Study Group. Study on Lipids with Isoptin Press.
Topics: Aged; Analysis of Variance; Antihypertensive Agents; Blood Pressure; Delayed-Action Preparations; Drug Therapy, Combination; Electrocardiography; Enalapril; Female; Heart Conduction System; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Lipids; Male; Middle Aged; Verapamil | 1993 |
Additive effects of verapamil and enalapril in the treatment of mild to moderate hypertension.
Topics: Adult; Aged; Analysis of Variance; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Quality of Life; Surveys and Questionnaires; Verapamil | 1995 |
Favourable interaction of calcium antagonist plus ACE inhibitor on cardiac haemodynamics in treating hypertension: rest and effort evaluation.
Topics: Adult; Aged; Blood Pressure; Drug Combinations; Drug Interactions; Enalapril; Exercise; Female; Heart; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Rest; Verapamil | 1995 |
Comparative effects of enalapril and verapamil on myocardial blood flow in systemic hypertension.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Cardiac Pacing, Artificial; Coronary Circulation; Dipyridamole; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Reproducibility of Results; Single-Blind Method; Tomography, Emission-Computed; Vasodilator Agents; Verapamil | 1997 |
[Changes in the quality of life influenced by treatment of primary arterial hypertension].
Topics: Adult; Antihypertensive Agents; Atenolol; Enalapril; Humans; Hypertension; Male; Middle Aged; Quality of Life; Verapamil | 1997 |
Treatment of hypertension after renal transplantation: long-term efficacy of verapamil, enalapril, and doxazosin.
Topics: Adult; Antihypertensive Agents; Calcium Channel Blockers; Doxazosin; Enalapril; Female; Follow-Up Studies; Graft Survival; Humans; Hypercholesterolemia; Hypertension, Renal; Kidney Failure, Chronic; Kidney Transplantation; Longitudinal Studies; Male; Middle Aged; Postoperative Complications; Verapamil | 1998 |
Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black People; Blood Pressure; Calcium Channel Blockers; Diastole; Diuretics; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Nifedipine; Practice Guidelines as Topic; Proportional Hazards Models; Sodium Chloride Symporter Inhibitors; South Africa; Time Factors; Treatment Outcome; Vasodilator Agents; Verapamil | 2001 |
Effects of drug therapy on cardiac arrhythmias and ischemia in hypertensives with LVH.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Atenolol; Blood Pressure; Electrocardiography, Ambulatory; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Ischemia; Treatment Outcome; Verapamil | 2001 |
Effect of two antihypertensive combinations on metabolic control in type-2 diabetic hypertensive patients with albuminuria: a randomised, double-blind study.
Topics: Aged; Albuminuria; Analysis of Variance; Antihypertensive Agents; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Multivariate Analysis; Probability; Prospective Studies; Spain; Treatment Outcome; Verapamil | 2001 |
A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Circadian Rhythm; Delayed-Action Preparations; Double-Blind Method; Enalapril; Female; Heart Rate; Humans; Hypertension; Losartan; Male; Middle Aged; Vasodilator Agents; Verapamil | 2002 |
Relationship between treatment-induced changes in left ventricular mass and blood pressure in black african hypertensive patients: results of the Baragwanath Trial.
Topics: Angiotensin-Converting Enzyme Inhibitors; Black People; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Diastole; Diuretics; Echocardiography; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Male; Methyldopa; Middle Aged; Nifedipine; Patient Compliance; Regression Analysis; South Africa; Systole; Verapamil | 2002 |
Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising.
Topics: Antihypertensive Agents; Blood Pressure; Circadian Rhythm; Delayed-Action Preparations; Double-Blind Method; Electrocardiography, Ambulatory; Enalapril; Female; Heart Rate; Humans; Hypertension; Losartan; Male; Statistics, Nonparametric; Systole; Verapamil | 2002 |
[The impact of antihypertensive therapy on cerebral hemodynamics in patients with metabolic syndrome].
Topics: Antihypertensive Agents; Biological Availability; Blood Pressure Monitoring, Ambulatory; Brain; Cerebrovascular Circulation; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Indapamide; Male; Metabolic Syndrome; Middle Aged; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Verapamil | 2012 |
Effects of oral enalapril and verapamil on dialysis adequacy and solute clearance in chronic ambulatory peritoneal dialysis.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Dialysis Solutions; Enalapril; Female; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Verapamil | 2013 |
57 other study(ies) available for verapamil and enalapril
| Article | Year |
|---|---|
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Design and synthesis of new potent N,N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; K562 Cells; Molecular Structure; Piperazine; Piperazines; Structure-Activity Relationship; Tumor Cells, Cultured | 2018 |
Effects of graded exercise on blood pressure, heart rate, and plasma hormones in cardiac transplant recipients before and during antihypertensive therapy.
Topics: Adult; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Drug Therapy, Combination; Enalapril; Epinephrine; Exercise Test; Female; Follow-Up Studies; Furosemide; Heart Rate; Heart Transplantation; Hormones; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Postoperative Complications; Renin; Verapamil | 1992 |
IgA-nephropathia in a patient with ankylosing spondylitis.
Topics: Enalapril; Glomerulonephritis, IGA; Hemoglobins; Humans; Immunoglobulin A; Kidney; Male; Middle Aged; Spondylitis, Ankylosing; Ultrasonography; Verapamil | 1992 |
Regression of left ventricular hypertrophy in hypertensive heart transplant recipients treated with enalapril, furosemide, and verapamil.
Topics: Adult; Cardiomegaly; Echocardiography; Electrocardiography; Enalapril; Female; Furosemide; Heart Transplantation; Heart Ventricles; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Verapamil | 1991 |
Importance of angiogenic action of angiotensin II in the glomerular growth of maturing kidneys.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Hydralazine; Kidney Glomerulus; Male; Rats; Verapamil | 1990 |
Effect of treatment with enalapril, verapamil and indomethacin on compensatory renal growth in the rat.
Topics: Animals; Body Weight; Enalapril; Hypertrophy; Indomethacin; Kidney; Male; Nephrectomy; Organ Size; Rats; Rats, Inbred Strains; Verapamil | 1990 |
Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enalapril; Felodipine; Hypertension; Kidney Failure, Chronic; Nephrectomy; Nitrendipine; Proteinuria; Rats; Rats, Inbred Strains; Verapamil | 1987 |
[Circadian behavior of blood pressure and heart rate following orthotopic heart transplantation. Studies before and during antihypertensive therapy].
Topics: Adult; Antihypertensive Agents; Blood Pressure; Circadian Rhythm; Enalapril; Female; Furosemide; Heart Rate; Heart Transplantation; Humans; Male; Postoperative Complications; Verapamil | 1989 |
[Calcium antagonists vs ACE inhibitors in the treatment of essential arterial hypertension in the aged].
Topics: Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Diltiazem; Drug Evaluation; Enalapril; Female; Humans; Hypertension; Male; Nifedipine; Verapamil | 1989 |
Long-term enalapril and verapamil in rats with reduced renal mass.
Topics: Animals; Enalapril; Female; Glomerulonephritis; Hypertension, Renal; Hypertrophy; Kidney; Nephrectomy; Proteinuria; Rats; Rats, Inbred Strains; Time Factors; Verapamil | 1989 |
[Effect of enalapril, furosemide and verapamil on cyclosporin concentration in whole blood].
Topics: Adult; Cyclosporins; Enalapril; Female; Furosemide; Heart Transplantation; Humans; Hypertension; Lung Transplantation; Male; Middle Aged; Prospective Studies; Verapamil | 1988 |
Diabetic nephropathy in the rat: differing renal effects of an angiotensin converting enzyme inhibitor and a calcium inhibitor.
Topics: Animals; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enalapril; Female; Glomerular Filtration Rate; Kidney; Proteinuria; Rats; Rats, Inbred Strains; Reference Values; Verapamil | 1988 |
[Calcium channel blockers and angiotensin converting enzyme inhibitors in the treatment of high blood pressure].
Topics: Calcium Channel Blockers; Captopril; Drug Interactions; Enalapril; Humans; Hypertension; Nifedipine; Oligopeptides; Teprotide; Verapamil | 1986 |
Aldosterone response to antihypertensive treatment.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Antihypertensive Agents; Atenolol; Blood Pressure; Dipeptides; Enalapril; Ethanolamines; Humans; Hypertension; Middle Aged; Prazosin; Pyridazines; Renin; Renin-Angiotensin System; Vasodilator Agents; Verapamil | 1982 |
New drugs for hypertension.
Topics: Antihypertensive Agents; Bumetanide; Diltiazem; Dipeptides; Enalapril; Guanabenz; Guanidines; Humans; Indapamide; Labetalol; Nifedipine; Pindolol; Verapamil | 1984 |
An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Coronary Disease; Diltiazem; Enalapril; Female; Heart Transplantation; Humans; Hyperplasia; Lisinopril; Male; Middle Aged; Nifedipine; Transplantation, Homologous; Tunica Intima; Ultrasonography, Interventional; Verapamil | 1995 |
Prevention of cardiac hypertrophy in experimental chronic renal failure by long-term ACE inhibitor administration: potential role of lysosomal proteinases.
Topics: Animals; Cathepsin B; Cathepsin H; Cathepsin L; Cathepsins; Cysteine Endopeptidases; Enalapril; Endopeptidases; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Myocardium; Rats; Rats, Wistar; Renin-Angiotensin System; Verapamil | 1995 |
Alterations in renal endothelin production in rats with reduced renal mass.
Topics: Animals; Enalapril; Endothelins; Erythropoietin; Hypertension, Renal; Kidney; Kidney Diseases; Male; Nephrectomy; Radioimmunoassay; Rats; Rats, Wistar; Recombinant Proteins; Verapamil | 1995 |
Prophylaxis of experimental bone marrow transplant nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bone Marrow Transplantation; Captopril; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Enalapril; Kidney; Kidney Diseases; Male; Proteinuria; Radiation Injuries, Experimental; Rats; Time Factors; Uremia; Verapamil; Whole-Body Irradiation | 1994 |
[Do ACE inhibitors potentiate snake venom? Severe and prolonged hypotension caused by adder bite].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antivenins; Drug Synergism; Enalapril; Humans; Hypotension; Male; Middle Aged; Snake Bites; Time Factors; Verapamil; Viper Venoms | 1993 |
ACE-inhibitors, calcium antagonists and low systemic vascular resistance following cardiopulmonary bypass. A case-control study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Cardiopulmonary Bypass; Case-Control Studies; Coronary Artery Bypass; Critical Care; Diltiazem; Dopamine; Enalapril; Female; Heart Valves; Humans; Length of Stay; Male; Middle Aged; Nifedipine; Norepinephrine; Retrospective Studies; Single-Blind Method; Syndrome; Vascular Resistance; Verapamil | 1993 |
Rat heart allograft survival after treatment with verapamil, captopril, and enalapril.
Topics: Animals; Captopril; Drug Interactions; Enalapril; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Rats; Rats, Inbred Strains; Time Factors; Transplantation, Homologous; Verapamil | 1995 |
Ineffectiveness of angiotensin converting enzyme inhibition (enalapril) on overt and silent myocardial ischemia in vasospastic angina and comparison with verapamil.
Topics: Angina Pectoris, Variant; Angiotensin-Converting Enzyme Inhibitors; Coronary Angiography; Electrocardiography; Enalapril; Exercise Test; Humans; Male; Middle Aged; Rest; Vasodilator Agents; Verapamil | 1996 |
Effects of aerobic training on exaggerated blood pressure response to exercise in African-Americans with severe systemic hypertension treated with indapamide +/- verapamil +/- enalapril.
Topics: Adult; Aged; Antihypertensive Agents; Black People; Blood Pressure; Combined Modality Therapy; Drug Therapy, Combination; Enalapril; Exercise Therapy; Humans; Hypertension; Indapamide; Male; Middle Aged; Verapamil | 1997 |
Effects of enalapril, losartan, and verapamil on blood pressure and glucose metabolism in the Cohen-Rosenthal diabetic hypertensive rat.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Disease Models, Animal; Enalapril; Glucose; Hypertension; Imidazoles; Losartan; Male; Rats; Rats, Inbred Strains; Tetrazoles; Verapamil | 1997 |
Obsessive-compulsive disorder: cerebral calcium deficiency as a possible etiologic/pathogenetic factor--a case study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Brain; Calcium; Calcium Channel Blockers; Enalapril; Humans; Hypertension; Male; Obsessive-Compulsive Disorder; Tachycardia, Paroxysmal; Verapamil | 1997 |
Effects of antihypertensive drugs on autoregulation of RBF and glomerular capillary pressure in SHR.
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Capillaries; Doxazosin; Enalapril; Homeostasis; Hypertension; Kidney; Kidney Glomerulus; Male; Nifedipine; Rats; Rats, Inbred SHR; Regional Blood Flow; Renal Circulation; Verapamil | 1998 |
Prolonged rat heart allograft survival after treatment with angiotensin converting enzyme inhibitor or a calcium antagonist.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Captopril; Drug Therapy, Combination; Enalapril; Female; Graft Survival; Heart Transplantation; Immunosuppression Therapy; Male; Rats; Rats, Inbred Strains; Time Factors; Transplantation, Homologous; Verapamil | 1998 |
Beta-adrenergic signalling and threshold adrenaline concentration for induction of fibrillation in the perfused heart pretreated with antihypertensive drugs.
Topics: Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Cyclic AMP; Enalapril; Epinephrine; GTP-Binding Proteins; In Vitro Techniques; Male; Metoprolol; Perfusion; Potassium; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Signal Transduction; Timolol; Verapamil | 1999 |
Individual or combined effects of enalapril and verapamil on chronic cyclosporine nephrotoxicity in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Cyclosporine; Drug Therapy, Combination; Enalapril; Endothelin-1; Gene Expression Regulation; Immunosuppressive Agents; Kidney Cortex; Male; Nephritis; Osteopontin; Procollagen; Rats; Rats, Wistar; RNA, Messenger; Sialoglycoproteins; Transforming Growth Factor beta; Verapamil | 1999 |
Effect of antihypertensive drugs on the myocardial microvessels in rats with nitric oxide blockade.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Capillaries; Coronary Circulation; Coronary Vessels; Disease Models, Animal; Enalapril; Enzyme Inhibitors; Heart; Hypertension; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Spironolactone; Verapamil | 2000 |
[Diabetic nephropathy with nephrotic syndrome--apropos of 2 cases. Advantages of combined conversion enzyme inhibitor and non-dihydropyridine calcium antagonist treatment].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Humans; Indoles; Kidney Function Tests; Male; Middle Aged; Nephrotic Syndrome; Verapamil | 2000 |
Volume-weighted mean nuclear volume and numerical nuclear density in the cardiomyocyte following enalapril and verapamil treatment.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Calcium Channel Blockers; Cell Nucleus; Enalapril; Enzyme Inhibitors; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Verapamil | 2001 |
Heart biometry and allometry in rats submitted to nitric oxide synthesis blockade and treatment with antihypertensive drugs.
Topics: Animals; Antihypertensive Agents; Body Weight; Enalapril; Heart; Heart Ventricles; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size; Rats; Rats, Wistar; Regression Analysis; Spironolactone; Verapamil | 2001 |
The effect of enalapril and verapamil on the left ventricular hypertrophy and the left ventricular cardiomyocyte numerical density in rats submitted to nitric oxide inhibition.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cell Count; Enalapril; Enzyme Inhibitors; Hypertrophy, Left Ventricular; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Plethysmography; Rats; Rats, Wistar; Statistics, Nonparametric; Verapamil | 2001 |
Stereology of cardiac hypertrophy induced by NO blockade in rats treated with enalapril and verapamil.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Apoptosis; Blood Pressure; Calcium Channel Blockers; Cardiomegaly; Enalapril; Male; Necrosis; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Verapamil | 2001 |
Cardiomyocyte volume-weighted nuclear volume and spironolactone therapy in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Cell Nucleus; Dose-Response Relationship, Drug; Enalapril; Hypertension; Male; Myocytes, Cardiac; Rats; Rats, Inbred SHR; Spironolactone; Time Factors; Verapamil | 2002 |
Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease.
Topics: Adult; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Captopril; Enalapril; Exercise; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Norepinephrine; Renal Circulation; Renal Plasma Flow, Effective; Verapamil | 2002 |
Aortic wall remodeling in rats with nitric oxide deficiency treated by enalapril or verapamil.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Calcium Channel Blockers; Disease Models, Animal; Drug Therapy, Combination; Enalapril; Heart Ventricles; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Verapamil | 2004 |
The use of low-dose insulin in cardiogenic shock due to combined overdose of verapamil, enalapril and metoprolol.
Topics: Antihypertensive Agents; Drug Synergism; Enalapril; Female; Humans; Hypoglycemic Agents; Insulin; Metoprolol; Middle Aged; Shock, Cardiogenic; Vasodilator Agents; Verapamil | 2006 |
Cardiovascular excitatory effect on rats of a fraction isolated from the eyestalk of shrimp: Peneaus vanameii.
Topics: Animal Structures; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Blood Pressure; Calcium Channels; Cardiotonic Agents; Dihydroergotamine; Drug Evaluation, Preclinical; Enalapril; Ganglia, Invertebrate; Heart Rate; Hemodynamics; Hypertension; Male; Motor Neurons; Neuropeptides; Penaeidae; Premedication; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Tachycardia; Tissue Extracts; Verapamil | 2006 |
A kinetic method for the determination of plasma protein binding of compounds unstable in plasma: Specific application to enalapril.
Topics: Adsorption; Animals; Blood Proteins; Centrifugation; Charcoal; Clinical Laboratory Techniques; Dextrans; Dialysis; Dogs; Drug Stability; Enalapril; Guinea Pigs; Humans; In Vitro Techniques; Piperazines; Protein Binding; Purines; Rats; Reproducibility of Results; Sildenafil Citrate; Sulfones; Time Factors; Verapamil; Warfarin | 2011 |
In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Carboxylesterase; Carboxylic Ester Hydrolases; Diltiazem; Drug Interactions; Enalapril; Esters; Humans; Hydrolysis; Inactivation, Metabolic; Indoles; Kinetics; Liver; Microsomes, Liver; Nitrophenols; Prodrugs; Ramipril; Recombinant Proteins; Verapamil | 2014 |
Development of eye drops containing antihypertensive drugs: formulation of aqueous irbesartan/γCD eye drops.
Topics: Antihypertensive Agents; Biphenyl Compounds; Enalapril; gamma-Cyclodextrins; Irbesartan; Ophthalmic Solutions; Permeability; Solubility; Tetrazoles; Verapamil | 2015 |
Multiple Time-of-Flight/Time-of-Flight Events in a Single Laser Shot for Improved Matrix-Assisted Laser Desorption/Ionization Tandem Mass Spectrometry Quantification.
Topics: Antihypertensive Agents; Enalapril; Humans; Lasers; Molecular Structure; Promethazine; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors; Verapamil | 2016 |